Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17459104 | 0.98 | ALDH1A1 (0.67) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL28461120 | 0.93 | ALDH1A1 (0.61) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL9192089 | 0.89 | ALDH1A1 (0.65) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL13316186 | 0.85 | ALDH1A1 (0.48) | ALDH1A1TSHRSMN1; SMN2TDP1SLC6A2 | |
| SCHEMBL17459122 | 0.85 | ALDH1A1 (0.58) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL8506264 | 0.85 | TSHR (0.54) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL3543222 | 0.83 | LMNA (0.53) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL7185515 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL3543227 | 0.83 | LMNA (0.53) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 | |
| SCHEMBL316845 | 0.83 | THRB (0.54) | ALDH1A1TSHRSMN1; SMN2LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112823792-B | Sustained release microsphere of galanthamine pamoate for injection and preparation method thereof | 鲁南制药集团股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-109563363-B | Formulation and process for producing highly conductive copper patterns | 铜打印科技有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-112823792-A | Galanthamine pamoate sustained-release microspheres for injection and preparation method thereof | 鲁南制药集团股份有限公司 | 2021-05-21 | — | — | CN | claimed |
| EP-3494184-A1 | FORMULATIONS AND PROCESSES FOR PRODUCING HIGHLY CONDUCTIVE COPPER PATTERNS | Copprint Technologies Ltd (IL) | 2019-06-12 | — | — | EP | claimed |
| WO-2018025271-A1 | FORMULATIONS AND PROCESSES FOR PRODUCING HIGHLY CONDUCTIVE COPPER PATTERNS | COPPRINT TECHNOLOGIES LTD (IL) | 2018-02-08 | — | — | WO | claimed |
| US-4665067-A | BACTERICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-05-12 | — | — | US | claimed |
| EP-4722293-A1 | METHOD FOR PRODUCING HIGHLY CONDUCTIVE COMPOSITION AFTER DRYING AND FIRING | Tatsuta Electric Wire & Cable Co., Ltd. (JP) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025233842-A1 | METHOD FOR PRODUCING CONDUCTIVE FILM, ELECTROMAGNETIC WAVE SHIELDING LAYER, ELECTRODE PATTERN, AND SINTERING DEVICE | RICOH COMPANY, LTD. (JP) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025045145-A1 | WRN HELICASE-INHIBITING BIS-HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | 广州科恩泰生物医药科技有限公司 | 2025-03-06 | — | — | WO | disclosed |
| WO-2025023272-A1 | METHOD FOR PRODUCING HIGHLY CONDUCTIVE COMPOSITION AFTER DRYING AND FIRING | タツタ電線株式会社 | 2025-01-30 | — | — | WO | disclosed |
| CN-119274843-A | Copper paste and method for producing copper paste | 常州聚和新材料股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20240327668-A1 | FORMULATIONS AND PROCESSES FOR PRODUCING HIGHLY CONDUCTIVE COPPER PATTERNS | COPPRINT TECHNOLOGIES LTD (IL) | 2024-10-03 | — | — | US | disclosed |
| US-11958783-B2 | Composition, film, and method for producing film | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-04-16 | — | — | US | disclosed |
| US-7781443-B2 | cholesteryl ester transfer protein (CETP) anatgonists such as 2R,4S)-4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(morpholin-4-yl)pyrimidin-2-yl]}amino-2-ethyl-6-methoxy-3,4-dihydro-2H-[1,5]naphthyridine-1-carboxylic acid ethyl ester, having improved bioavailability | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-08-24 | — | — | US | disclosed |
| EP-2181985-A1 | Antiviral Agent | SHIONOGI & CO., LTD. (JP) | 2010-05-05 | — | — | EP | disclosed |
| US-7217424-B2 | Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA, INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-20070032485-A1 | Tetrahydronaphthyridine derivatives and a process for preparing the same | TANABE SEIYAKU CO., LTD. | 2007-02-08 | — | — | US | disclosed |
| WO-2005010011-A2 | METHODS OF SYNTHESIS OF ACYLOXYALKYL COMPOUNDS | XENOPORT, INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| US-20040229909-A1 | Antiviral agent | SHIONOGI & CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229909-A1 | Antiviral agent | ZC3HAV1, ZC3HAV1L, DUT | ALDH1A1 658/4885TSHR 4237/4885SMN1; SMN2 3953/4885 |
| US-20070032485-A1 | Tetrahydronaphthyridine derivatives and a process for preparing the same | CETP, MTTP, NPC1L1 | ALDH1A1 3511/4885TSHR 386/4885SMN1; SMN2 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.